CD8A and neoplasm: OVs can attract CD8+ T-cells and NK cells to TME and induce PD-L1 on the surface of tumor cells, thus eliminating the lack of immune cells in the TME and facilitating blocking for ICIs, thereby enhancing the antitumor effect [192].